Iaso Ventures — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
CatenaBio develops precision conjugation technology using native amino acids to enable biotherapeutic fusions of small molecules, nucleic acids, enzymes, and cells.
BiotechDeep TechHealthtechMedical DevicesBerkeley, US
Marco Lobba(Founder)inMatthew Francis(Founder)inGeo Guillen
Co-investorsCalifornia Innovation FundCivilization Ventures Management, LlcCreative Destruction Lab (CDL)FREEFLOWGaingelsJude Gomila+14 more
Ryght AI provides an artificial intelligence-powered platform that uses digital twin technology to help clinical research organizations and sponsors identify and select optimal sites for clinical trials.
AI & Machine LearningBiotechHealthtechMedical Devices
Dr. Chadi Nabhan(Chief Medical Officer)Tom Pike(President and Chief Executive Officer)
Co-investorsAIX VenturesFoothill VenturesPage One VenturesVirtue VenturesLDV PartnersTop Harvest Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.



__Twitter.png)






